• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk

Filters [Clear]
  • Price Sensitive: Yes
AAH Suspension from Official Quotation at close 02/07/09PRICE SENSITIVE02/07/09
AAH Form 6021 - Compulsory Acquisition following T/O bidPRICE SENSITIVE25/06/09
AAH Cephalon has relevant interest in 90.41% of SharesPRICE SENSITIVE15/06/09
AAH Cephalon International - No decision on offer extensionPRICE SENSITIVE10/06/09
AAH Extension of Offer PeriodPRICE SENSITIVE01/06/09
AAH Cephaon International t/o offer now unconditionalPRICE SENSITIVE20/05/09
AAH Notice Under Section 650F - Free of Defeating ConditionsPRICE SENSITIVE20/05/09
AAH Arana Half Year ReportPRICE SENSITIVE14/05/09
AAH Independent Directors of Arana Accept into Cephalon's OfferPRICE SENSITIVE13/05/09
AAH Supplementary Bidder's StatementPRICE SENSITIVE11/05/09
AAH Variation of Takeover BidPRICE SENSITIVE23/04/09
AAH Supplementary Bidder's StatementPRICE SENSITIVE16/04/09
AAH Supplementary Target's StatementPRICE SENSITIVE08/04/09
AAH Supplementary Bidder's StatementPRICE SENSITIVE01/04/09
AAH Arana granted patents in AustraliaPRICE SENSITIVE23/03/09
AAH Shareholder Update - Bid from CephalonPRICE SENSITIVE10/03/09
AAH Arana successfully completes Phase II psoriasis studyPRICE SENSITIVE09/03/09
AAH Arana Final Share Buyback Notice Appendix 3FPRICE SENSITIVE03/03/09
AAH Cancellation share buyback Announcement 5 cents dividendPRICE SENSITIVE02/03/09
AAH Cephalon Launches Takeover OfferPRICE SENSITIVE27/02/09
AAH Arana announces takeover discussionsPRICE SENSITIVE26/02/09
AAH Trading HaltPRICE SENSITIVE26/02/09
AAH Arana announ. discontinuance of PMX53 for ocular indicationsPRICE SENSITIVE19/02/09
AAH Arana announces issuance of key European patent for EvibodiePRICE SENSITIVE09/02/09
AAH Arana commences international Phase II trial in RAPRICE SENSITIVE11/12/08
AAH Arana Therapeutics Completes Second Project for GSKPRICE SENSITIVE27/11/08
AAH Arana commences ART621 Phase II rheumatoid arthritis trialPRICE SENSITIVE26/11/08
AAH Suspension from Official Quotation at close 02/07/09
02/07/09PRICE SENSITIVE
AAH Form 6021 - Compulsory Acquisition following T/O bid
25/06/09PRICE SENSITIVE
AAH Cephalon has relevant interest in 90.41% of Shares
15/06/09PRICE SENSITIVE
AAH Cephalon International - No decision on offer extension
10/06/09PRICE SENSITIVE
AAH Extension of Offer Period
01/06/09PRICE SENSITIVE
AAH Cephaon International t/o offer now unconditional
20/05/09PRICE SENSITIVE
AAH Notice Under Section 650F - Free of Defeating Conditions
20/05/09PRICE SENSITIVE
AAH Arana Half Year Report
14/05/09PRICE SENSITIVE
AAH Independent Directors of Arana Accept into Cephalon's Offer
13/05/09PRICE SENSITIVE
AAH Supplementary Bidder's Statement
11/05/09PRICE SENSITIVE
AAH Variation of Takeover Bid
23/04/09PRICE SENSITIVE
AAH Supplementary Bidder's Statement
16/04/09PRICE SENSITIVE
AAH Supplementary Target's Statement
08/04/09PRICE SENSITIVE
AAH Supplementary Bidder's Statement
01/04/09PRICE SENSITIVE
AAH Arana granted patents in Australia
23/03/09PRICE SENSITIVE
AAH Shareholder Update - Bid from Cephalon
10/03/09PRICE SENSITIVE
AAH Arana successfully completes Phase II psoriasis study
09/03/09PRICE SENSITIVE
AAH Arana Final Share Buyback Notice Appendix 3F
03/03/09PRICE SENSITIVE
AAH Cancellation share buyback Announcement 5 cents dividend
02/03/09PRICE SENSITIVE
AAH Cephalon Launches Takeover Offer
27/02/09PRICE SENSITIVE
AAH Arana announces takeover discussions
26/02/09PRICE SENSITIVE
AAH Trading Halt
26/02/09PRICE SENSITIVE
AAH Arana announ. discontinuance of PMX53 for ocular indications
19/02/09PRICE SENSITIVE
AAH Arana announces issuance of key European patent for Evibodie
09/02/09PRICE SENSITIVE
AAH Arana commences international Phase II trial in RA
11/12/08PRICE SENSITIVE
AAH Arana Therapeutics Completes Second Project for GSK
27/11/08PRICE SENSITIVE
AAH Arana commences ART621 Phase II rheumatoid arthritis trial
26/11/08PRICE SENSITIVE
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.